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Although the effects of insulin on glucose and lipid
metabolism are well documented, gaps remain in our
understanding of the precise molecular mechanisms of
signal transduction. Recent evidence suggests that com-
partmentalization of signaling molecules and metabolic
enzymes may explain the unique cellular effects of the
hormone. Signal initiation from the insulin receptor is
restricted in part to caveolae microdomains of the plasma
membrane. A fraction of the insulin receptor directly
interacts with caveolin, thus directing the protein to
caveolae. Following its activation by insulin, the receptor
recruits a series of adapter proteins, resulting in the
activation of the G protein TC10, which also resides in
caveolae. TC10 can influence a number of cellular pro-
cesses, including changes in the actin cytoskeleton,
recruitment of effector including the adapter protein
CIP4, and assembly of the exocyst complex. These events
play crucial roles in the trafficking, docking and fusion of
vesicles containing the insulin-responsive glucose
transporter Glut4 at the plasma membrane.
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Insulin promotes the synthesis and storage of carbohydrates,
lipids and proteins, and inhibits their degradation and release
back into the circulation. Insulin action is characterized by a
diverse variety of effects at the cellular level, including
changes in vesicle trafficking, stimulation of protein kinases
and phosphatases, promotion of cellular growth and differen-
tiation, and activation or in some cases, repression of
transcription. This complexity suggests that insulin action
must involve multiple signaling pathways that diverge at or
near the activation of its tyrosine kinase receptor. In fact, it is
likely that even individual effects of the hormone require
multiple signaling inputs. Evidence is emerging that the
coordination of these pathways might be governed by their
intracellular compartmentalization. We will consider how
spatial aspects of signal transduction play a critical role in
determining the specificity of insulin action, with particular
attention to the role of caveolae and lipid rafts.
Divergent Signaling Pathways Are Initiated by
Insulin Receptor Substrates
The insulin receptor is a tyrosine kinase that catalyzes the
phosphorylation of several intracellular substrates, includ-
ing the insulin receptor substrate (IRS) proteins (1): GAB-1
(2), Shc (3), APS (4), p60DOK (5), and c-Cbl (6). Each of
these substrates recruits a distinct subset of signaling
proteins containing Src homology 2 (SH2) domains,
which specifically interact with sequences surrounding
the phosphotyrosine. Moreover, each of these substrates
may be compartmentalized to distinct locations in the cell,
due to sequences that direct interactions with proteins or
lipids.
Most attention in the field of insulin receptor substrates
has focused on the IRS family of proteins. Mice lacking the
IRS-1 protein are insulin resistant, but do not develop
diabetes unless crossed to mice in which another signaling
molecule has been disrupted (7–9). Animals lacking IRS-2
exhibit both impaired glucose tolerance and diabetes (10),
which appears to result from a defect in insulin secretion
as well as insulin resistance, presumably due to decreased
beta cell proliferation in the face of increased demand for
insulin. The tyrosine phosphorylation of IRS family mem-
bers generates docking sites for a number of SH2-containing
proteins (1). Among these, the predominant partner seems to
be the p85 regulatory subunit of the type 1A phosphati-
dylinositol (PI) 3-kinase. Inhibition of the p110 PI 3-kinase
catalytic activity with pharmacological inhibitors such aswort-
mannin, expression of dominant-interfering mutants, or
microinjection of blocking antibodies can completely prevent
most actions of insulin (11,12). Consistentwith the necessary
requirement for the product of PI 3-kinase (PI-3,4,5P3), over-
expression of the PI 30 phosphatase pTEN or the PI 50
phosphatase SHIP also block the action of insulin.
Although these data demonstrate the necessity of PI
3-kinase, several lines of evidence indicate that activation
of the enzyme is not sufficient. For example, dramatic
overexpression of constitutively active mutants of PI
3-kinase can only partially stimulate the translocation of
the insulin-responsive glucose transporter protein Glut4
(13). Other growth factors, such as PDGF and IL-4, or
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certain adhesion molecules, stimulate PI 3-kinase to an
extent similar to that seen with insulin, but have only a
minor effect on glucose uptake and Glut4 translocation
(14–16). In addition, cell-permeable derivatives of PIP3
alone cannot mimic the stimulation of glucose uptake by
insulin, but can stimulate when cells are pretreated with
insulin and a pharmacological inhibitor of PI 3-kinase (17).
Furthermore, several studies have demonstrated that
exercise, contraction and hypoxia can all induce glucose
uptake andGlut4 translocation in skeletalmuscle independent
of any detectable PI 3-kinase activation (18). Taken together,
these data suggest that insulin must generate at least two
independent signals to stimulate glucose transport: one
dependent on and another independent of PI 3-kinase.
Moreover, theactivationofPI3-kinasebynon-insulinomimetic
hormones suggests that the second pathwaymust be unique
for insulin.
As indicated above, PI 3-kinase catalyzes the phosphoryl-
ation of phosphatidylinositol-4,5P2 (PIP2) to generate phos-
phatidylinositol-3,4,5-trisphosphate (PIP3). PIP3 serves as
an allosteric regulator of the phosphoinositide-dependent
kinase (PDK1) (19), that phosphorylates and activates both
Akt (also known as PKB), as well as the atypical protein
kinase C isoforms PKCz and PKCl (19,20). PIP3 appears
to mediate the translocation of Akt to the plasma
membrane, via its pleckstrin homology (PH) domain (21).
PKCz?L and PDK1 translocate to the plasma membrane by
this same mechanism. Although there are data to support
an essential role for these kinases in glucose transport, the
precise identity of the physiologically relevant kinase and
the subsequent downstream targets remains uncertain
(22,23). Also uncertain is whether these protein kinases
migrate to new sites upon activation, or whether there is
local activation that impacts on Glut4 translocation.
Glucose Transport Is Regulated by Changes in
the Location of Glut4
As mentioned above, insulin-stimulated glucose uptake is
primarily mediated by the facilitative transporter Glut4, one
member of a large family of related transporters, that is
highly expressed in adipose tissue, skeletal and cardiac
muscle (24). In the basal state, Glut4 slowly recycles
between the plasma membrane and vesicular compart-
ments within the cell, where most of the Glut4 resides.
Insulin stimulates the translocation of a pool of Glut4 to the
plasma membrane, through a process of targeted
exocytosis. At the same time, Glut4 endocytosis is
attenuated, resulting in a dramatic increase in glucose
uptake (25). Thus, the rate of glucose transport into fat
and muscle cells is governed by the concentration of Glut4
at the cell surface, and the duration for which the protein is
maintained at this site.
While there is substantial evidence that Glut4 exists in
specialized vesicles sequestered within the cell, the pre-
cise intracellular location and trafficking pathways of these
vesicles are unclear. Glut4 is localized in tubulovesicular
and vesicular structures that are biochemically distinct
from the recycling endosomal network. Furthermore, the
Glut4 compartment is enriched in the v-SNARE (soluble
N-ethylmaleimide sensitive factor attachment protein
receptor) protein VAMP2 but not the related VAMP3/
cellubrevin isoform that is present in recycling endosomes
(25). Consistent with these data, ablation of transferrin
receptor containing endosomes does not impair insulin-
stimulated Glut4 translocation.
Substantial evidence suggests that the plasma membrane
target for the GLUT4 vesicle is the t-SNARE, syntaxin 4
(Syn4) (26–29). Thus, the docking of the vesicle may be
mediated by the interaction of Syn4 with the Glut4 vesicle
v-SNARE protein, VAMP2. Several proteins have been
demonstrated to bind to Syn4, including SNAP23 (30),
Munc18c (31) and Synip (32), and thereby regulate the
docking and fusion of VAMP2-containing GLUT4 vesicles.
Among these, Synip has been shown to undergo an insulin-
dependent dissociation from Syn4, allowing VAMP2 to
bind to the protein (32). Moreover, recent evidence has
suggested that Syn4 might reside in lipid raft subdomains
of the plasmamembrane (33,34), and further that Glut4may
transit through lipid rafts (35,36).
PI 3-Kinase-Independent Pathways in the
Regulation of Glucose Transport: The Role of
Caveolae
A potential clue towards identifying the PI 3-kinase-
independent arm of insulin action emerged from the idea
that signal initiation might be segregated into discrete
compartments in the plasma membrane. One candidate
for such a compartment is the caveolae, small invaginations
of the plasma membrane that are a subset of lipid raft
domains. These localized regions are enriched in lipid-
modified signaling proteins, GPI-anchored proteins, glyco-
lipids, sphingolipids and cholesterol (37). Insulin stimulates
the tyrosine phosphorylation of caveolin, the major struc-
tural protein in caveolae (38–40). Further investigation into
this pathway revealed that at least a fraction of the insulin
receptor was segregated into these plasma membrane
microdomains (41). Although the mechanism by which
this sorting of the receptor occurs remains unknown, recent
studies reveal that the insulin receptor associates with
caveolin (40). Moreover, disruption of the Caveolin 1 gene
results in the degradation of the insulin receptor in fat cells,
and the subsequent disruption of insulin action in these
cells, along with insulin resistance (42).
The identification of the insulin receptor in caveolae allows
for the segregation of a signaling pathway separate from
the activation of PI 3-kinase and downstream events.
Insulin stimulates the phosphorylation of another insulin
receptor substrate, the protooncogene c-Cbl (6). The
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insulin-stimulated phosphorylation of Cbl occurs only in
metabolically responsive cell lines, and not in other fibroblast
lines, despite the presence of Cbl and an active receptor (6).
This phosphorylation event requires the adapter protein
APS, which recruits Cbl to the insulin receptor (4). APS has
a PH domain that is required for membrane localization, and
an SH2 domain that interacts with the phosphorylated
receptor. After recruitment to the activated receptor, the
protein subsequently undergoes tyrosine phosphorylation
at a specific residue in the C-terminus of the protein. Upon
phosphorylation, APS recruits Cbl by interacting with an
atypical SH2 domain of the latter protein. Interestingly,
both APS and Cbl are recruited to the receptor as dimers
(Liu et al., submitted).
The Cbl-associated protein (CAP) was identified in a
two-hybrid screen using Cbl as bait (43). CAP contains three
carboxyl terminal SH3 domains, the last ofwhichmediates its
binding to Cbl. CAP is expressed predominantly in insulin-
sensitive tissues and in differentiated 3T3-L1 adipocytes, but
not in preadipocytes. Expression of theCAPgene is increased
by the insulin-sensitizing thiazolidinediones (TZDs) (44). TZD
activation of the nuclear receptor PPARg directly activates the
transcription of CAP through a PPARg response element in its
promoter (45). Moreover, TZD-stimulated increases in CAP
expression lead to a more robust phosphorylation of Cbl in
response to insulin (44), establishing a potential primary link
between TZD-induced insulin sensitization and insulin signal
transduction.
The localization of CAP in lipid rafts appears to result from
its association with the hydrophobic protein flotillin. This
interaction was localized to amino terminal sequences of
CAP that contain homology to the gut peptide Sorbin,
which we referred to as the Sorbin Homology (SoHo)
domain (46). Dominant interfering SH3 deletion mutants
of CAP that bind to flotillin, but not Cbl, or SoHo deletion
mutants that bind to Cbl, but not flotillin, interfere with the
localization of Cbl to lipid rafts. Moreover, these mutants
specifically block insulin-stimulated Glut4 translocation and
glucose uptake (46,47). The overall architecture found in
CAP, with an amino terminal SoHo and carboxyl-terminal
SH3 domains is found in a number of other proteins,
including vinexin and ArgBP2 (46). It is likely that these
proteins represent a new family that is responsible for the
localization of signaling or cytoskeletal proteins to lipid
rafts (46).
The G Protein TC10 Is Crucial to the
Stimulation of Glucose Transport by Insulin
Once phosphorylated, Cbl can recruit the SH2-containing
adapter protein CrkII to caveolae, along with the guanine
nucleotide exchange factor C3G (48). C3G then appears to
activate the two Rho family proteins TC10a and b (49).
These small GTP binding proteins are expressed in fat
and muscle, and can be acutely activated by insulin in
a CAP-dependent but PI 3-kinase-independent manner.
Activation of TC10 is specific for insulin, and disruption of
its activation blocks insulin-stimulated glucose transport and
Glut4 translocation (48). Although TC10 activation is required
for insulin-stimulated glucose uptake, it is not sufficient.
Constitutive activation of the protein by overexpression
of C3G in 3T3L1 adipocytes does not mimic insulin action,
but does potentiate the actions of the hormone, shifting the
insulin dose-response curve (48). Moreover, coexpression
of C3G with an active mutant of PI 3-kinase fully restores
insulin action, suggesting that these two pathways provide
synergistic signals in the regulation of glucose transport
(Figure 1).
One clue to the specificity of TC10 activation lies in its unique
carboxyl terminal-targeting motif. Unlike other members of
the Rho family that undergo geranylgeranylation and interact
with guanyl nucleotide dissociation inhibitors, TC10 is likely to
undergo both farnesylation and palmitoylation in a manner
analogous to that of H-Ras. These post-translational modifica-
tions are responsible for the targeting of TC10 to lipid raft
domains (50). Moreover, mistargeting of TC10 into nonlipid
raft regionsof theplasmamembraneprevents its activationby
insulin and alters the ability of TC10 to modulate insulin-
stimulated Glut4 translocation. In addition, disruption of lipid
raftswith cholesterol-extractingdrugsor by overexpressionof
inhibitory formsofcaveolin completelyblocksTC10activation,
as well as the stimulation of glucose transport by insulin (50).
While the precise effectors responsible for the actions of
TC10 remain unknown, a potential clue towards under-
standing its function has emerged from prior studies on
the established role of Rho proteins in the regulation of the
actin cytoskeleton. In fibroblasts, Rho proteins control
actin stress fibers, lamelipodia and filopodia (51). Multiple
studies have also demonstrated a functional requirement
for filamentous (F)-actin in insulin-stimulated Glut4 trans-
location and glucose uptake. For example, severing of
F-actin with cytochalasin D or depolymerization by the
monomeric actin-sequestering agent Latrunculin effect-
ively inhibit insulin-stimulated Glut4 translocation (52–54).
Similarly, inhibition of Rho function with difficile toxin B or
expression of the amino terminal domain of TC10 disrupts
the adipocyte actin cytoskeleton and inhibits Glut4 trans-
location (Hou and Pessin, in press). Although it remains to
be determined whether TC10 mediates the regulation of
cortical actin polymerization in adipocytes by insulin, this
small GTP binding protein can directly interact with
numerous effector molecules that are known to modulate
cytoskeletal function in other cells (55).
Identification of TC10 Effectors in Insulin
Action
While the precise role of TC10 in insulin’s actions requires
further investigation, a number of candidate molecules
have emerged as effectors for the protein. One of these
is a splice variant of the adapter protein, CIP4. This
protein was first identified as an effector of Cdc42. The
Insulin Action and Caveolae
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multidomain structure of CIP4 isoforms suggests that this
family of proteins may serve an adapter function. CIP4
contains an FCH domain, two coiled-coil domains, and an
SH3 domain. The FCH domain interacts with microtubules,
and the second coiled-coil domain interacts with TC10 in a
GTP-dependent manner. CIP4 localizes to an intracellular
compartment under basal conditions, and translocates to
the plasma membrane upon insulin stimulation (56).
Overexpression of constitutively active TC10 brings CIP4/
2 to the plasma membrane, whereas overexpression of an
inhibitory form of TC10 blocks the translocation of CIP4/2
produced by insulin. Overexpression of mutant forms of
CIP4/2 containing an N-terminal deletion or with diminished
TC10 binding inhibits insulin-stimulated Glut4 translocation,
suggesting that CIP4/2 may play an important role in insulin-
stimulated glucose transport as a downstream effector of
TC10.
TC10 also interacts with one of the components of the
exocyst complex, Exo70, in a GTP-dependent fashion (57).
The exocyst complex has been implicated in the tethering
or docking of secretory vesicles. Exo70 translocates to the
plasma membrane in response to insulin via the activation
of TC10, where it assembles a multiprotein complex that
includes Sec6 and Sec8, as well as additional proteins that
have not yet been identified. Overexpression of an Exo70
mutant blocks insulin-stimulated glucose uptake, but not
the trafficking of Glut4 to the plasma membrane. How-
ever, this mutant did block the extracellular exposure of
the Glut4 protein. These data suggest that the exocyst
may play a critical role in the targeting of the Glut4 vesicle
to the plasma membrane, perhaps directing the vesicle to
the precise site of fusion.
Temporal and Spatial Determinants of
Specificity in Insulin Action
Although the molecular targets of the PI 3-kinase and CAP/
Cbl pathways are uncertain, one possibility is that they
regulate different processes (Figure 1). For example,
PIP3-dependent kinases may phosphorylate proteins
involved in the tethering of the Glut4 vesicle at intracellular
sites, leading to the release and default trafficking of the
vesicle to the plasma membrane. On the other hand, the
CAP/TC10 pathway may regulate processes involved in
the trafficking, docking and fusion of the vesicle at the
plasma membrane.
Even in insulin-responsive cells and tissues, there are
numerous other tyrosine kinases and G protein-coupled
receptors that can lead to the activation of lipid and protein
kinase pathways similar to those activated by insulin, with-





















Figure 1: An insulin signaling pathway in caveolae. Two signaling pathways are required for the translocation of the glucose
transporter GLUT4 by insulin in fat and muscle cells. A separate pool of the receptor interacts with caveolin, and catalyzes the tyrosine
phosphorylation of this protein. Upon activation, the receptor recruits the adaptor protein APS, which undergoes phosphorylation on a
single tyrosine. This results in the recruitment of the protooncogene Cbl, which subsequently undergoes phosphorylation by the receptor.
Cbl constitutively interacts with CAP, which can bind to the lipid raft protein flotillin to stabilize the recruitment of this complex in caveolae.
The recruitment of phosphorylated Cbl into the lipid raft results in the recruitment of the SH2/SH3 adapter protein CrkII, via an interaction
of the SH2 domain of CrkII with phospho-Cbl. CrkII constitutively binds to the nucleotide exchange factor C3G, which can catalyze the
exchange of GTP for GDP on the lipid raft-associated protein TC10. Upon activation, TC10 initiates a separate signaling pathway that, along
with the PIP3-dependent protein kinases, can stimulate the trafficking of the GLUT4 vesicle, along with its docking and fusion with plasma
membrane.
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hormone. One potential clue towards solving this dilemma of
specificity might involve temporal and spatial restrictions on
signaling. For example, the rapid termination of insulin
signaling by phosphatases or retrophosphorylation pathways
could play a key role in delineating the downstream effects of
the hormone, perhaps preventing the propagation of signals
such as those produced by the persistent activation of the
MAP kinase pathway that lead to oncogenesis or inflamma-
tion. The spatial compartmentalization of signaling might also
play an important role in insuring specificity. For example, the
spatial segregation of Cbl and downstreammolecules allows
for the activation of TC10 in a restricted domain of the plasma
membrane, the lipid raft. In this way, TC10 activation is
specific for insulin, and targets effectors in a well-defined
region of the cell. While we may have a handle on many of
the critical pathways that cells use to respond to hormones,
it is likely that teasing out their relationship in space and time
will allow us to understand how they produce their unique
physiological effects.
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